Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Tarentula Hispana 8 X Drops ; Globules ; Granules is a Health Canada–registered human drug (DIN 02234156) held by Homeocan Inc., containing Tarentula Hispana. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2009). Nexara Health has matched 1 registration of Tarentula Hispana across 1 other regulated market.

Health Canada registration

DIN02234156
Brand nameTarentula Hispana
Active ingredientTarentula Hispana
Strength8 X
Dosage formDrops ; Globules ; Granules
RouteOral
CompanyHomeocan Inc.
StatusCancelled Post Market — 04 Aug 2009
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Tarentula Hispana registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesBestmade Natural Products Tarentula HispBestmade Natural ProductsTablet, SolublelistedFDA NDC

See every manufacturer of Tarentula Hispana worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Tarentula Hispana (DIN 02234156) marketed in Canada?

No. Health Canada lists DIN 02234156 as Cancelled Post Market as of 04 Aug 2009.

Who holds the Canadian licence for this product?

Homeocan Inc. is the company of record in the Health Canada Drug Product Database.

Is Tarentula Hispana registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02234156, status date 2009-08-04; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02234156, status date 2009-08-04; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02234156, status date 2009-08-04; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.